ArticleMolecular therapy oncolytics2021

Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism.

Ping Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.